0001181431-14-033367.txt : 20141002
0001181431-14-033367.hdr.sgml : 20141002
20141002175847
ACCESSION NUMBER: 0001181431-14-033367
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140930
FILED AS OF DATE: 20141002
DATE AS OF CHANGE: 20141002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Pharma plc
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ADELAIDE CHAMBERS
STREET 2: PETER STREET
CITY: DUBLIN
STATE: L2
ZIP: 8
BUSINESS PHONE: 011-353-1-649-8521
MAIL ADDRESS:
STREET 1: ADELAIDE CHAMBERS
STREET 2: PETER STREET
CITY: DUBLIN
STATE: L2
ZIP: 8
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE VAERE ROBERT J
CENTRAL INDEX KEY: 0001240116
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 141137813
MAIL ADDRESS:
STREET 1: C/O HORIZON PHARMA, INC
STREET 2: 1033 SKOKIE BLVD, SUITE 355
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
4
1
rrd416999.xml
X0306
4
2014-09-30
1
0001492426
Horizon Pharma plc
HZNP
0001240116
DE VAERE ROBERT J
C/O HORIZON PHARMA PLC
ADELAIDE CHAMBERS, PETER STREET
DUBLIN, IRELAND
L2
8
IRELAND
0
1
0
0
EVP & CFO
Ordinary Shares
2014-09-30
4
A
0
112166
0
A
206456
D
Ordinary Shares
2014-09-30
4
S
0
51942
12.28
D
154514
D
Fully vested restricted stock units issued on the Separation Date as defined in that certain Executive Employment and Transition Agreement dated June 17, 2014.
Includes 23,467 shares of the Company's ordinary shares acquired pursuant to an employee stock purchase program.
Reflects restricted stock units surrendered via a net settlement to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit.
/s/ Paul W. Hoelscher, Attorney-in-Fact
2014-10-02